Florian Brand (Atai Life Sciences): Psychedelics – The New Psychiatric Frontier | Slush 2021
Channel: Slush
Date: 06/12/2021

Every once in a while, interest in psychedelics as a way to treat mental health disorders is evoked. There’s an extensive body of scientific research dedicated to studying psychedelics and their effect on mental health, yet suspicion towards them is deeply ingrained in collective memory. The path to patients is hard to find, both due to general scepticism as well as regulatory challenges.

Atai Life Sciences is a mental health unicorn thriving in an extremely difficult environment. Now, its Co-Founder and CEO Florian Brand will walk us through the state of research, path to patients and navigating the regulatory landscape.